Evidence map›Paper›PMID 32328884›Full record

GuidelineCerebellum (London, England)2020

Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias.

Marios Hadjivassiliou, Francesc Graus, Jerome Honnorat, Sven Jarius, Maarten Titulaer, Mario Manto, Nigel Hoggard, Ptolemaios Sarrigiannis, Hiroshi Mitoma

Open access · hybridAbstract readPractice GuidelineReview
In one paragraph

Guideline in Cerebellum (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A case of autoimmune cerebellar ataxia associated with anti-neurochondroitin antibody.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Investigating ITM2B-associated ataxia in a Taiwanese cerebellar ataxia cohort.Annals of clinical and translational neurology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 7 countries.

Marios HadjivassiliouAcademic Department of Neurosciences, Sheffield Teaching hospitals NHS Trust and University of Sheffield, Sheffield, UK. m.hadjivassiliou@sheffield.ac.uk.
Francesc GrausNeuroimmunology Program, Institut d'Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Jerome HonnoratHopital Neurologique, Lyon, France.
Sven JariusMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Maarten TitulaerDepartment of Neurology, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Mario MantoUnite des Ataxies Cerebelleuses, CHU-Charleroi, Service des Neurosciences, UMons, Charleroi, Belgium.
Nigel HoggardAcademic Department of Neuroradiology, Sheffield Teaching hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Ptolemaios SarrigiannisAcademic Department of Neurosciences, Sheffield Teaching hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Hiroshi MitomaTokyo Medical University, Tokyo, Japan.
Sheffield Teaching Hospitals NHS Foundation Trust · GBConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESErasmus MC · NLGrand Charleroi Hospital · BEHeidelberg University · DEInstitut NeuroMyoGène · FRTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aside from well-characterized immune-mediated ataxias with a clear trigger and/or association with specific neuronal antibodies, a large number of idiopathic ataxias are suspected to be immune mediated but remain undiagnosed due to lack of diagnostic biomarkers. Primary autoimmune cerebellar ataxia (PACA) is the term used to describe this later group. An International Task Force comprising experts in the field of immune ataxias was commissioned by the Society for Research on the Cerebellum and Ataxias (SRCA) in order to devise diagnostic criteria aiming to improve the diagnosis of PACA. The proposed diagnostic criteria for PACA are based on clinical (mode of onset, pattern of cerebellar involvement, presence of other autoimmune diseases), imaging findings (MRI and if available MR spectroscopy showing preferential, but not exclusive involvement of vermis) and laboratory investigations (CSF pleocytosis and/or CSF-restricted IgG oligoclonal bands) parameters. The aim is to enable clinicians to consider PACA when encountering a patient with progressive ataxia and no other diagnosis given that such consideration might have important therapeutic implications.

Indexed as

Autoimmune Diseases of the Nervous SystemCerebellar AtaxiaHumansImmune ataxiasPrimary autoimmune cerebellar ataxia (PACA)

Identifiers

PMID32328884
PMCPMC7351847
OpenAlexW3018274789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.